We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Capital Bancorp
CBNK
$614M
| $335K | ﹤0.01% |
20,125
-5,690
| -22% | -$116K |
|
|
EVBG
977
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $334K | ﹤0.01% |
+9,635
| New | +$308K |
|
978
DigitalBridge
DBRG
$2.95B
| $333K | ﹤0.01% |
+27,782
| New | +$349K |
|
979
Crawford & Co Class A
CRD.A
$625M
| $331K | ﹤0.01% |
39,570
-2,100
| -5% | -$13.7K |
|
980
First Commonwealth Financial
FCF
$2.18B
| $331K | ﹤0.01% |
26,609
-2,400
| -8% | -$34.6K |
|
|
CTRA
981
DELISTED
Coterra Energy
CTRA
| $330K | ﹤0.01% |
+13,457
| New | +$331K |
|
982
Advanced Energy
AEIS
$13.6B
| $329K | ﹤0.01% |
3,354
| – | – |
|
983
IPG Photonics
IPGP
$3.63B
| $328K | ﹤0.01% |
+2,664
| New | +$309K |
|
984
Scansource
SCSC
$1.06B
| $328K | ﹤0.01% |
10,791
-208
| -2% | -$6.46K |
|
|
P
985
Everpure Inc
P
$39.1B
| $328K | ﹤0.01% |
12,857
| – | – |
|
986
MarineMax
HZO
$1.15B
| $327K | ﹤0.01% |
11,375
-617
| -5% | -$19.4K |
|
987
Apple Hospitality REIT
APLE
$3.75B
| $326K | ﹤0.01% |
21,020
+407
| +2% | +$6.66K |
|
988
Stoke Therapeutics
STOK
$2.09B
| $325K | ﹤0.01% |
39,055
-1,358
| -3% | -$12.3K |
|
989
Air Products & Chemicals
APD
$67.8B
| $323K | ﹤0.01% |
1,124
-42
| -4% | -$12.3K |
|
990
Public Service Enterprise Group
PEG
$37.8B
| $322K | ﹤0.01% |
+5,155
| New | +$312K |
|
991
Peoples Bancorp
PEBO
$1.48B
| $320K | ﹤0.01% |
12,417
-360
| -3% | -$10.4K |
|
|
SNCY
992
DELISTED
Sun Country Airlines
SNCY
| $319K | ﹤0.01% |
+15,576
| New | +$303K |
|
|
AVID
993
DELISTED
Avid Technology Inc
AVID
| $318K | ﹤0.01% |
+9,931
| New | +$294K |
|
994
Southern Missouri Bancorp
SMBC
$851M
| $318K | ﹤0.01% |
8,488
-160
| -2% | -$7.2K |
|
995
Magnolia Oil & Gas
MGY
$6.15B
| $316K | ﹤0.01% |
14,453
-34,516
| -70% | -$766K |
|
|
LSXMK
996
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $315K | ﹤0.01% |
14,550
-17,323
| -54% | -$456K |
|
997
Celsius Holdings
CELH
$7.16B
| $315K | ﹤0.01% |
10,179
-3,987
| -28% | -$126K |
|
998
MetroCity Bankshares
MCBS
$1.04B
| $313K | ﹤0.01% |
18,322
-10,078
| -35% | -$197K |
|
|
EVRI
999
DELISTED
Everi Holdings
EVRI
| $311K | ﹤0.01% |
18,155
-2,154
| -11% | -$37.2K |
|
|
PWSC
1000
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $306K | ﹤0.01% |
15,441
-8,333
| -35% | -$182K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.